TL;DR: 🟡 Directional, not significant — liberal transfusion trended toward better neurologic outcome in TBI but didn't reach significance; investigators still favor liberal as "most likely preferred," though a pooled meta-analysis found no clear difference.
1. Publication
- Title: Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury
- Acronym: HEMOTION
- Year & Journal: New England Journal of Medicine, published June 13, 2024
- Citation: Turgeon AF, Fergusson DA, Clayton L, et al; HEMOTION Trial Investigators. N Engl J Med. 2024. doi:10.1056/NEJMoa2404360
2. Context & Rationale
Background: TBI causes the most trauma-related deaths; optimal hemoglobin transfusion threshold post-injury was unknown, with prior restrictive-transfusion paradigms (from general critical illness) not specifically validated in TBI, where cerebral oxygen delivery is uniquely important.
Research Question/Hypothesis: In critically ill adults with moderate/severe TBI (GCS 3-12) and anemia, does a liberal transfusion strategy (Hb≤100 g/L trigger) reduce unfavorable neurologic outcome at 6 months compared with a restrictive strategy (Hb≤70 g/L trigger)?
3. Design & Methods
- Study Type: International, pragmatic, randomized, open-label, blinded-endpoint RCT
- Setting & Centers: 34 hospitals, Canada, UK, France, Brazil
- Population: Adults with moderate/severe TBI and anemia (Hb<100 g/L), mean lowest Hb ~84 g/L; mean ICU stay 15 days
- Intervention: Liberal — transfusion trigger Hb≤100 g/L
- Comparator: Restrictive — transfusion trigger Hb≤70 g/L
- Statistical Power & Follow-Up: Primary: unfavorable neurologic outcome (GOS-E) at 6 months.
4. Key Results
Outcome | Liberal | Restrictive | Notes |
Unfavorable neurologic outcome at 6mo (primary, GOS-E) | Numerically lower | — | Not statistically significant, but directionally favored liberal |
Note per trial group's own statement: "Although the observed beneficial effect on the GOS-E was not statistically significant, the overall findings suggest that a liberal strategy is most likely the preferred option to use in this patient population."
5. Internal Validity Assessment
International, pragmatic, blinded-endpoint RCT across 34 hospitals. Overall: Moderate-to-strong — well-conducted, blinded-endpoint trial; the study was explicitly NOT designed to test noninferiority of the restrictive strategy, so potential harm from restriction cannot be excluded, per an independent Medscape summary. Baseline imbalances in prognostic variables between groups were also noted as a possible influence on results.
6. External Validity Assessment
Multinational (Canada, UK, France, Brazil) moderate/severe TBI population with anemia — broadly representative of TBI populations in similarly resourced trauma systems.
7. Strengths & Limitations
Strengths: Large, international, pragmatic, blinded-endpoint design; directly addresses a genuine, previously unresolved TBI-specific transfusion question.
Limitations: Study population limited to anemic patients (higher baseline unfavorable-outcome risk); potential baseline imbalances; open-label treatment; not designed as a noninferiority test of the restrictive arm, so harm cannot be fully excluded.
8. Interpretation & Practice Impact
Does not statistically confirm that liberal transfusion improves neurologic outcomes in TBI, but the directional signal (plus the concordant TRAIN trial, this handbook's 2024 Neurocritical Care category) suggests liberal transfusion is "most likely the preferred option" per the investigators — a nuanced, not fully definitive, practice signal.
9. Controversies & Subsequent Evidence
A subsequent systematic review/meta-analysis (5 RCTs, 1528 patients, Ann Intensive Care 2024) found restrictive transfusion had no impact on mortality (RR 1.00) or unfavorable neurologic outcome (RR 1.06, 95% CI 0.94-1.20) versus liberal, while reducing transfusion units — a more cautious, pooled conclusion than the individual HEMOTION investigators' framing. This contrasts interestingly with TRAIN (this handbook), a broader acute-brain-injury trial that DID find a significant liberal-transfusion benefit — together these trials paint a genuinely nuanced, TBI-specific-vs-broader-brain-injury picture that the field is still reconciling.
10. Summary & Executive Takeaway
Summary: HEMOTION randomized adults with moderate/severe TBI and anemia across 34 international hospitals to liberal (Hb≤100) or restrictive (Hb≤70) transfusion. The primary outcome (unfavorable neurologic outcome at 6 months) trended favorably for liberal transfusion but did not reach statistical significance.
Overall Takeaway: HEMOTION provides a directionally favorable, but not statistically definitive, signal toward liberal transfusion in TBI — investigators themselves interpret this as supporting liberal transfusion as the "most likely preferred" strategy, though a subsequent pooled meta-analysis of 5 RCTs found no significant difference in mortality or neurologic outcome, illustrating genuine, ongoing uncertainty in this specific population.
11. Bibliography
- Taccone FS, et al. TRAIN Randomized Clinical Trial. JAMA. 2024;332(19):1623-1633 (this handbook).
- Efficacy of restrictive versus liberal transfusion strategies in TBI: systematic review and meta-analysis. Ann Intensive Care. 2024;14:158.